Studio NaVA - National Study on Quality of Life in Adolescents Affected by Allergic Rhinitis With or Without Asthma

Studio NaVA - Studio Nazionale Sulla Qualità Della Vita in Adolescenti Con Rinite Allergica Con e Senza Asma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02380495

Enrollment

1200

Registered

2015-03-05

Start date

2015-03-31

Completion date

2017-03-31

Last updated

2017-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis, Asthma

Keywords

Adolescents, Respiratory Pathology

Brief summary

Studio Nava is a National Study aiming to assess allergic rhinitis and asthma outcomes on Quality of Life and Quality of Sleep in adolescent patients by means of Web Survey. Studio Nava also proposes the innovative use of a web platform (http://nava.ibim.cnr.it/) that contains all standardized tools (medical-healthcare web form, ACT, Asthma control test; PSQI, Pittsburgh Sleep Quality Index; T5SS, Total Symptom Score; modified SIDRIA for adolescents; Rhinasthma; VAS scale), that will be available for the doctors after the registration to the web platform. Downloaded questionnaires will be delivered to case-patient, asking him/her to fill them during the waiting time of the visit.

Interventions

OTHERData Collection

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

14 Years to 17 Years

Healthy volunteers

Inclusion criteria

* Clinical cases n°: 600 adolescents affected by allergic rhinitis with/without asthma, from 14 to 17 years age. * Controls n°: 600 subject (5 for each participant Pediatrician) of the same age range, without respiratory pathology.

Exclusion criteria

* Subjects that have not allergic rhinitis with/without asthma diagnosis or are \<14 years old or \>17 years old

Design outcomes

Primary

Measure	Time frame
Assessment of the allergic rhinitis impact on quality of life	2 weeks

Secondary

Measure	Time frame
The impact of AR and asthma on quality of sleep	2 weeks

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026